MolDX: Prometheus® IBD sgi Diagnostic® Policy

This policy states the Prometheus IBD sgi Diagnostic test, including its 17 biomarkers and proprietary Smart Diagnostic Algorithm, is not covered for distinguishing IBD from non-IBD or for differentiating Crohn disease from ulcerative colitis. No indications for coverage, frequency limits, or documentation requirements are specified in the policy.

"The Prometheus IBD sgi Diagnostic test (including its serologic markers, genetic SNPs, inflammatory biomarkers, and proprietary algorithmic IBD score) is non-covered for use to differentiate inflam..."

Sign up to see full coverage criteria, indications, and limitations.